Brian Kim

Fluent BioSciences, Inc. is a privately funded biotechnology company based in Watertown, MA. The company's mission is to revolutionize single-cell biology through accessible, affordable, and scalable solutions for every researcher. Fluent Biosciences aims to accelerate the understanding of biology and disease through its breakthrough pre-templated instant partitions (PipSeq™) technology, which facilitates near-instantaneous self-assembly of individual cells or molecules into millions of uniform partitions without the need for complex instrumentation or expensive consumables. The company was founded in 2018 by Adam Abate, Sepehr Kiani, and Bill Hyun, and Sepehr Kiani has been the CEO since 2018.

Scribe Biosciences, Inc. operates as a biotechnology company. The company is based in San Francisco, CA. The company was founded by Srinivasan Maithreyan, Zev Gartner, Adam Abate, Russell Cole. The CEO is Russell Cole.

Part of Yuga Labs, Inc., Wenew, Inc. operates as an online platform for the development of apparel brands. The company is based in Los Angeles, CA. The company was founded by Mike Winkelmann, Tim Smith, Michael H. Figge, Guy Oseary. Michael H. Figge has been the CEO since incorporation. Wenew was acquired by Yuga Labs, Inc. on November 14, 2022.

Mirvie, Inc. provides precise, actionable, non-invasive tests for maternal-fetal health. The company is headquartered in South San Francisco, CA.

Grail Ltd. develops blood-plasma tests to detect deadly diseases at their earliest stages when curative treatments are viable. The firm focuses on the early detection of cancer. The company was founded in Dennis Lo, Rossa Chiu, and Allen Chan in 2014 and is headquartered in Hong Kong.

BFLY Operations, Inc. develops medical imaging device. It transforms diagnostic and therapeutic imaging with devices, deep learning and the cloud. The company was founded by Tyler Ralston, Jonathan M. Rothberg, Max Tegmark, Gregory L. Charvat and Nevada Sanchez in 2011 and is headquartered in Guilford, CT.

ValueFirst Digital Media Pvt. Ltd. provides digital communication software solutions. It offers enterprise communications, social media, and media solutions and platforms for customers to send mobile messages online. The firm's product provides mobile messaging, voice messages, e-mail, wireless application protocol, mobile video, and social media that facilitate interactions between marketers and clients. The company was founded by Vishwadeep Bajaj, Shantanu Singh Chauhan and Vijay Shukla in 2003 and is headquartered in Gurgaon, India.

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

Ion Torrent Systems, Inc. develops semiconductor chips for DNA sequencing systems. The company was founded in 2007 and is headquartered in Guilford, CT.

Genoa Ventures LLC (Genoa Ventures) is an independent private equity/venture capital firm founded in 2018 by Jenny Rooke. The firm is headquartered in San Francisco, California.

PlumCare LLC provides family healthcare advisory services. The private company is based in Alameda, CA. The company was founded by Petros Tsipouras, Paul R. Billings.

The Bethesda Group Fund invests in companies located in US. The fund target companies operating in the fields of Precision Medicine, Digital Health and Molecular Diagnostics. It provides financing for both early and growth stage capital requirements.

OmniSeq, Inc. operates molecular diagnostic laboratory. It offers two NGS-based assays: Immune Report CardSM and OmniSeq ComprehensiveSM. The company was founded by Carl Morrison in 2015 and is headquartered in Buffalo, NY.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Applied Immunology, Inc. provides specialty assay solutions for the development of therapeutics and diagnostics. It offers custom cell-based assays, GLP bio-analytical assays, and immune monitoring. The company was founded in 2011 and is headquartered in Redwood City, CA.

Biological Dynamics, Inc. engages in the development of cancer diagnostic solutions for labs and homes. Its platform offers a way to isolate cell-free nanoparticles and macromolecules directly from whole blood, serum, or plasma. The firm also develops a suite of oncology tests for early cancer detection, treatment response, and recurrence monitoring. The company was founded by Raj Krishnan, Edward D. Truitt III, Michael J. Heller, Roy Lefkowitz, and David Charlot in 2008 and is headquartered in San Diego, CA.

DecisionQ Corp. offers machine learning, computer science, applied statistics and business leadership. Its provides products and services to financial sector, managed care industries, molecular and genetic diagnostics, insurance and reinsurance, retail, consumer packaged goods, logistics and national defense. The company was founded by Todd A. Radano in 1996 and is headquartered in Arlington, VA.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

EMD Millipore Corp. engages in the provision of laboratory materials, technologies, and services to the life science industry. The company was founded by Jack Bush in 1954 and is headquartered in Burlington, MA.

Essen Instruments, Inc. engages in the development and manufacture of cell and bead based screening solutions. It offers phenotypic drug discovery, antibody discovery and in vitro toxicity testing. The firm’s proprietary technologies, instrumentation, assays and software products address the pervasive need to provide turnkey solutions that increase productivity in pharmaceutical, biotechnology and life science research. The company’s products are used in biologics discovery, small molecules, in vitro tox and cellular research antibody applications. The company was founded by R. Terry Dunlay, Larry A. Sklar, and Bruce S. Edwards in 2006 and is headquartered in Ann Arbor, MI.

Accellix, Inc. develops in-vitro diagnostic systems. Its Accellix platform is an affordable tabletop diagnostic device with single-use assay cartridges that does not require extensive training nor involve complex operational processes. The firm’s product is an application for the rapid identification of sepsis, a condition associated with high morbidity and mortality with no existing rapid diagnostic test. The company was founded in 2009 by Julien Meissonnier and Harvey Kasdan and is headquartered in San Jose, CA.

Part of Moelis & Co., Moelis & Co. (UK) LLP is an independent investment bank that provides confidential and unconflicted strategic advice to clients across various industries. The company is based in London, UK. Leveraging their extensive network of 21 geographic locations, the British company delivers the best solutions to their clients. Mark Jonathan Aedy has been the CEO of the company since 2010.

Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom.

Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark.

Akadeum Life Sciences, Inc. provides diagnostics services. The firm is developing a new product that uses BACS (buoyancy-activated cell sorting) to acquire target cells from biological samples by using tiny floating spheres called ?microbubbles? and disposable microbubble collectors. The company was founded by Brandon H. McNaughton and John Younger in March 2014 and is headquartered in Ann Arbor, MI.

Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets.

Accuri Cytometers, Inc. develops and manufactures personal flow cytometers for researchers. It operates as a life sciences company which develops and markets high performance cell analysis systems designed to bring the power of flow cytometry into life science and biomedical laboratories. The firm offers C6 Flow Cytometer, a bench-top cell and bead analysis system used in various applications, such as immunophenotyping, bacteria analysis, cell cycle analysis, proliferation assays, apoptosis, DNA analysis, target multiplexing, gene expression, lineage analysis, viability, absolute cell counts, intracellular cytokines, membrane potential, yeast and algae analysis, and phagocytosis. The company was founded by Jennifer A. Baird and Collin A. Rich in 2004 and is headquartered in Ann Arbor, MI.

Zephyrus Biosciences, Inc. provides tools for protein analysis at the single cell level. The firm's products include Z1 instrument, zWest Kits, and scWestern system which enables western blotting on individual cells. Its products are used to gain insights into the biology of cancer, stem cells, neurology, and human disease and development. The company was founded by Kelly Gardner, Amy E. Herr and Joshua Molho in 2013 and is headquartered in Berkeley, CA.